growth in recent years and in 2019 alone the company signed over 100 licensing contracts with global partners.

Adalvo is a leading B2B company servicing a global list of top tier clients with a differentiated, high-value portfolio. Adalvo has established itself as a reliable global partner with commercial partnerships in more than 60 countries and with over 40 commercial partners, globally. Adalvo’s headquarters are in Malta, with additional offices in more than 15 countries such as Switzerland, UK, Netherlands, Spain, Iceland, Austria, Romania, Hungary, Bulgaria, Portugal, Czech Republic, Singapore, China and India.

Adalvo prides itself on helping its partners reach their goals – whether that’s increasing revenues or pushing into new markets. While clients are the highest priority, Adalvo is also committed to its purpose and mission to accelerate the growth and development of employees and local communities. Adalvo tirelessly strives for excellence in all of its endeavours, driven by a deep-rooted passion to making a difference for partners. The company’s purpose driven culture is committed to improving the lives of patients around the world.

Adalvo’s partners like to be bigger, better and smarter in the dynamic pharmaceutical sector. That’s why the Adalvo approach is unique, customised and challenges the status quo that helps partners achieve their business goals.

Adalvo’s dynamic leadership team brings significant experience and industry know-how that has already helped established the company as a reliable global partner. The company constantly looks for new ways to delight and deliver and with its fast moving team Adalvo continually redefines what is possible.